Stock Analysis
Morpho Second Quarter 2024 Earnings: EPS: JP¥39.76 (vs JP¥22.23 loss in 2Q 2023)
Morpho (TSE:3653) Second Quarter 2024 Results
Key Financial Results
- Revenue: JP¥886.0m (up 62% from 2Q 2023).
- Net income: JP¥204.0m (up from JP¥114.0m loss in 2Q 2023).
- Profit margin: 23% (up from net loss in 2Q 2023). The move to profitability was driven by higher revenue.
- EPS: JP¥39.76 (up from JP¥22.23 loss in 2Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Morpho's share price is broadly unchanged from a week ago.
Risk Analysis
We should say that we've discovered 3 warning signs for Morpho (1 is significant!) that you should be aware of before investing here.
Valuation is complex, but we're helping make it simple.
Find out whether Morpho is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're helping make it simple.
Find out whether Morpho is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About TSE:3653
Morpho
Engages in the research, development, and licensing of artificial intelligence (AI) and image processing technologies in Japan, the United States, China, South Korea, Europe, and internationally.
Flawless balance sheet with poor track record.